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Within the last few years improvements in power sources and leads, as well as micro-processor technology, have resulted in smaller, longer lasting, and improved pacing devices. This has enabled the clinician to normalize cardiac function more completely through retention of atriovenlricular synchrony and to make periodic adjustments in pacing system performance which might reduce late morbidity and mortality. In addition, as a result of these more physiologic pacing modes, the longevity and quality of life of these patients with bradyarrhythmias may be substantially improved over that achieved with ventricular pacing alone. It seems germane, therefore, to summarize the current status of patients with symptomatic bradyarrhythmias treated over the previous two decades with ventricular pacing in order to 1) describe survivorship and causes of late mortality; 2) to identify those conditions in the patient population which correlate with a poor prognosis; 3) to enumerate the causes of late morbidity and mortality; and 4) to discuss how improvements in pacing system technology BRADYARRYTHMIAS FOLLOWJNC VENTR1CUJ.AR PACEMAKER IMPLANTATION might improve survival. Data of this type would appear to be necessary in order to measure accurately any effects future technology may have on this patient population.
Methods

Patient Selection
The records of all adult patients who received their initial permanent pacemaker implantation at the University of Michigan were reviewed. These patients have been the subjects of several previous reports from this institution on indications, techniques, and complications of implantation and natural history of patients wilh permanent pacemakers.'"'" This report continues follow-up observations to December 31, 1979 for all patients receiving their initial pacemaker implant prior to April 1, 1979 . Data on past history, the indication for pacemaker placement, subsequent clinical course, and complications were summarized and the data transferred to computer tape. Data were analyzed using standard statistical methods. The MIDAS," and IGSAS'-data analysis systems were utilized. Differences between groups were analyzed by chi squared method, and survival was determined by the life table method.''•'•' The Breslow's generalized Kruskal-Wallis Test was utilized to determine if the survival distribution differed across strata for any single preimplantation variable.'T he etiology of underlying heart disease for patients in this series was based on the available clinical data at the time of diagnosis of the bradyarrhythmia, Electrocardiographic criteria alone were used for classification of subgroups; electrophysiologic studies were employed in only a few patients after 1972. Criteria for admission into each etiologic category were similar to that previously described [e.g.. whether the apparent underlying heart disease was arteriosclerotic. hypertensive, rheumatic, congenital, valvular, or due to a cardiomyopathy).'' Patients were considered to have "idiopathic conduction system disease" if there was no underlying valvular, myocardial. arteriosclerotic or hypertensive disease, and heart size was normal or nearly so, without congestive heart failure at initial implantation.
Determination of the Cause of Death
Details concerning the circumstances of death were obtained by interview with family members, the patient's physician, and other informed witnesses. All available medical records including autopsy data were reviewed whenever possible. Mortality data on deaths after 1972 were collected within six weeks of death, while data on those who died prior to 1972 were obtained, in part, retrospectively. Sudden death was defined as death within one hour after the onset of symptoms. Death due to myocardial infarction was based on a definite history of sustained typical ischemic precordial chest pain and other symptoms which terminated in death and whenever possible, supplemented by ECG, enzyme, or autopsy confirmation. Congestive heart failure was diagnosed by the criteria of McKee.'" For the purposes of this report, only adults (over age 21) were included whose indication for pacing was a bradyarrhythmia. Experience with children with permanent pacemaker implants from this institution will be reported upon elsewhere.'" A few adults paced for ventricular tachyarrhythmias in the mode of "overdrive" suppression, and one patient paced with an antitacbycardia device are not included in this report. Since 1965, patients were followed in a pacemaker clinic no less frequently tban every six months. For the patients who were followed outside the institution, telephone or written reports on cardiovascular status were obtained annually. During the follow-up interval patients were paced with General Electric* Medtronic,** Cordis.f and CPI:|: pacing systems.
Results
Description of the Population
The 399 adult patients included in this report were divided into three categories according to their specific bradyarrhythmia. The indication 'General Eleclric, Milwaukee, Wisconsin. U.S.A.
•'Medtronic, Inc., Minneapolis, Minnesota, U.S.A. fCordis Corp., Miami, Florida, U.S.A. :j:Cardiac Pacemakers, Inc., Si. Paul. Minnesota, U.S.A. for pacing and age distrihution for the patients is shown on Figure 1 . There were 312 patients with atrioventricular block (AVBl, 75 patients with sinus node disorders (SND), and 12 patients with hypersensitive carotid sinus syndrome [HCSS] , In this population, 44% had no apparent heart disease at the time of their initial implant, 30% had ischemic heart disease. Valvular heart disease was present in 1B%, and congenital heart disease in 2% (Table I) . One patient had a bullet wounc to the heart resulting in AV block, and one patient had leukemia and intermittent sepsis, either one of which may have been responsible for AV block. Approximately onethird of the patients were under the age of 65, one-third were 65-74. and one-third over age 75 at the time of initial pacemaker implantation [ Table I ]. Sixty-two percent were male. There were no significant differences in age distribution between the two major bradyarrhythmia categories-AV block and sinus node disorders-but the group with hypersensitive carotid sinus syndrome was younger. The sinus node group had a larger percentage with ischemic heart disease and less with aortic valve disease. Hypertension, congestive heart failure, cerebrovascular disease, diabetes, chronic renal disease, cancer, and obstructive lung disease were common in the study sample [Table II ). There were no significant differences in the prevalence of the specified associated illnesses in the three bradyarrhythmia categories. The AV block group had a higher prevalence of cardiomegaly, possibly corresponding to a higher prevalence of hypertension. Diabetes mellitus was very prevalent in all categories and far more common than in age matched controls, as has been previously reported.""'" Within the sinus node disease group. 13 (17%) had sinus bradycardia alone, 34 (45%) had sinus bradycardia in combination with symptomatic sinoatrial arrest, and 28 (37%) had sinus bradycardia and sinoatrial arrest in combination with supravenIricular arrhythmias-the "bradycardia-tachycardia syndrome."
Survival
The current status of the patient population is outlined in Table III . Only 1'/. of tbe patients were lost to follow-up. Forty-eight percent died. Death was most commonly due to underlying cardiac disease as manifested by sudden death in 41 (21% of all deaths), congestive heart failure [15% of deaths], myocardial infarction (9%). and arrhythmias (5'/(). Sudden death was the single most common cause of death in the AV block group, while congestive heart failure was most common in the sinus node group (Table  III) . Stroke and malignancy were the major causes of noncardiac death. Six deaths were attributed to complications of a thoracotomy-all of these occurred prior to 1965 when all implants were performed by this technique. Two deaths occurred within one week of a transvenous implant and were attributed to acute myocardial infarction. Twenty-one of the 22 patients whose cause of death was unknown died prior to 1972 when the cause of death was not ascertained within six weeks of death. Pacemaker failure was the documented cause of death in only three patients, but was suspected in several additional cases. Two patients, known to be pacemaker dependent, died suddenly within one month of a new transvenous lead implantation, and one patient who died suddenly was being paced with a pulse generator from series known to have a "no-output" failure mode.
Actuarial survival was virtually identical in the two major bradyarrhythmia categories. Survival in the AV block group was 88, 79, 60 and 49%. at one, two, five and 10 years, respectively [ Fig. 2 ). while the sinus node group had an 85.79, and 65% survival at one, two, and five years [p = N.S,) (Fig. 3) . The sinus bradycardia subgroup of patients with sinus node disease had a sligblly ' Expressed as a percent of ali patients.
*" Expressed as a percent of all deaths.
better long-term prognosis (72% survival at five years) than those with sinoatriai arrest or bradytachy syndrome [67% and 64% five-year survival, respectively) but the difference was not statistically significant. The preimplant variables which were associated with a poor survival included advanced age, especially in the AV block group [ Fig. 2) , the presence of congestive heart failure, especially in the sinus node group (Figs. 4, 5) , and most importantly, the presence of ischemic or hypertensive heart disease in both groups (Figs. 6 and 7] . Patients with AV block and sinus node disease associated with ischemic heart disease have been shown to have poor survival.*'^" The high-risk group also includes those with apparent primary myocardial disease [ Fig. 6 ). Those patients with valvular heart disease, either on a rheumatic basis or with isolated aortic valve disease, and patients with only idiopathic conduction system disease did distinctively better. Although there was a trend toward poorer survival in those treated early in the pacing era, possibly due to a higher perioperative mortality with epicardial electrodes, this was not statistically significant (p<.3). The subgroup with hypersensitive carotid sinus syndrome had no deaths until the eighth year, possibly because of the low prevalence of ischemic heart disease and the younger age. Table IV ). Congestive heart failure was the single most common late morbid event in this group. During the follow-up period, 33 (10.6%) of the AV block group and 5 (7%) of the sinus node group developed CHF. In only 18 of the 134 with CHF prior to pacemaker implantation did all clinical evidence of it disappear to the point where digitalis and diuretics could be discontinued indefinitely during follow-up. In six patients these drugs were discontinued for an extended period only to be required again later. De novo CHF, which required treatment, was diagnosed in 33 of 166 [21%] of the AV block group free of CHF prior to implant. While 86 patients in the AV block group had had a valvular component to their heart disease, Ihe valve disease was felt to be incidental in 20 (e.g., papillary muscle dysfunction secondary to ischemic heart disease, etc]. Fifty-two have not required valve replacement; in three, the pacemaker implantation preceded eventual valve replacement; in nine, pacemaker and valve replacement occurred during the same hospitalization [5 because of iatrogenic AV block and in 4 because of preoperative arrhythmias); in 12 patients valve replacement had been accomplished prior to eventual pacemaker implantation.
Late Morbid Events in the Population
Discussion
The poor overall survivorship with both sinus node disorders and AV block is consistent with reports from elsewhere'""'' and extends for another four years the observations made from this institution reported previously.""" Patients paced for hypersensitive carotid sinus syn- Figure 5. A (rend is seen in the AV block group between late survival and the presence of congestive heart failure prior to implant. drome appear to do better-probably because of younger age and lower prevalence of ischemic heart disease, and congestive heart failure. In fact, no deaths occurred for the first eight years of follow-up in this latter group of paced patients.
The patient population with symptomatic bradyarrhythmias which require permanent pacemaker placement is generally an elderly one with a high prevalence of cardiac and noncardiac physical ailments. The correlation between age at initial implant and poor survival has been reported in multiple previous studies, as well as from this series. Patients with pacemakers, in addition, have a higher than expected age-specific mortality than the population at large.^°'^' Poor survival was also highly correlated with left ventricular dysfunction prior to implantation and an ischemic or hypertensive etiology of the underlying heart disease."'''^'^* The poor survival in the presence of congestive heart failure for patients with AV block or sinus node disease was apparent in earlier reports from this series; an even poorer survival has been reported in other series. Laczkovics," for example, has reported a 50% mortality at 36 months in patients paced for CHF; Castberg" reported a 50% mortality in a similar group of patients at 48 months. More physiologic pacing modes (e.g., atrioventricular sequential, DVI] have been demonstrated to improve cardiac output in selected patients when compared to ventricular pacing and might, therefore, be expected to improve survivorship for those patients who succumb to the complications of CHF, but clinical evidence for tbis has not been presented.
The high mortality, despite pacing, in tbe sinus node subgroup, especially in those patients with coexistent ischemic heart disease or congestive heart failure, deserves special emphasis-only 337f. surviving over 36 months. There is growing evidence that, unlike patients paced for AV block, prolongation of life has not been demonstrated in patients with sinus node disease when compared to a non-paced population.-^ Other potentially reversible causes of cardiac mortality (e.g., major ventricular arrhythmias, myocardial ischemia, etc.) should be searched for and treated if survivorship is to be improved in this subgroup. Pacing appears mainly to bring symptomatic relief from syncope in such patients.
The distribution of causes of late death are consistent with studies reported elsewhere."'-" Complications of underlying heart disease were the major cause of death in all reported series. In this series sudden death was more common in the group with AV block, while congestive heart failure was the more common mode of death in patients with sinus node disease. Pacemaker malfunctions as a demonstrated cause of late death is uncommon in all series in which this was mentioned."'"'-'"'^" Determination of pacing system integrity immediately prior to or after death was made in only a few who died suddenly in this series, however.
Potential Implications of Improved Technology
Improvements in patient follow-up techniques and pacing system programmability may improve patient prognosis in the future. Telephone monitoring, currently used extensively for early detection of battery depletion, can also detect asymptomatic pacing system malfunction which might otherwise lead to early mortality. as well as detect potentially malignant arrhythmias amenable to treatment.
Multiprogrammahility, especially output adjustability, appears to be most useful in reducing early operative intervention to correct system malfunction." It may. however, also reduce the risk of early acute threshold elevation in pacemaker-dependent individuals. Sensitivity adjustability may prevent falal arrhythmias which can occasionally result from poor sensing of competing rhythms.
Heart failure that accompanies AV block or other bradyarrhythmias is partially due to the bradyarrhythmia itself and to impaired left ventricular function and persistent cardiomegaly. Continued reliance on digitalis and diuretics for continued hemodynamic stability after pacing is generally required.'" Whether the maintenance of atrioventricular synchrony with more physiologic pacing systems will not only improve cardiac output, as has been demonstrated in acute studies, bul also actually prevent death due to progressive ventricular dysfunction and prolong survival remains to he determined. In addition to advances in pacemaker technology, other improvements in the management of patients with clinically important bradyarrhythmias will continue, as they have throughout this clinical series. The early application of coro- Expressed as percent of those free of condition prior to implant.
nary revascularization and valve replacement, as well as more effective pharmacologic methods of control of congestive heart failure and tachyarrhythmias, will make measurement of the effect of any one intervention mode difficult. Because of the multiple apparent variables which contribute to morbidity and mortality in the paced population, it will be difficult to demonstrate that multiparameter programmability or dual chamber pacing will prolong survivorship despite evidence that it can reduce morbidity and enhance the quality of life of these patients.
